Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 16.0B | 15.0B | 14.9B | 14.1B |
Cost of revenue | 5.2B | 4.8B | 4.8B | 5.1B |
Gross profit | 10.7B | 10.2B | 10.1B | 9.0B |
Operating expense | ||||
Research & development | 3.1B | 2.7B | 2.3B | 2.2B |
Selling general and admin | 1.1B | 1.1B | 949M | 1.0B |
Other operating expenses | — | — | — | — |
Operating income | 6.1B | 5.9B | 6.4B | 4.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 807M | 769M | 873M | 916M |
Other income expense | 18M | -61M | -69M | -727M |
Pretax income | 5.3B | 5.1B | 5.5B | 3.8B |
Tax provision | 1.1B | 120M | -13M | -442M |
Net income | 4.1B | 5.0B | 5.5B | 4.3B |
Basic EPS | 0.9 | 1.1 | 1.2 | 0.9 |
Diluted EPS | 0.9 | 1.0 | 1.1 | 0.9 |
Basic average shares | 4.7B | 4.7B | 4.7B | 4.7B |
Diluted average shares | 4.9B | 4.8B | 4.8B | 4.8B |
EBITDA | 8.5B | 8.1B | 8.7B | 7.6B |
Net income from continuing op. | 4.1B | 5.0B | 5.5B | 4.3B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |